Skip to main content
Log in

ABSTRACTS: ISoP Annual Conference ‘Joining Forces for Managing Risks’ Liège, Belgium 11–13 October, 2006

  • Abstracts
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Répertoire Commenté des Médicaments 2006/Gecommentarieerd Geneesmiddelenrepertorium 2006, edited by the Belgian Center for Pharmacotherapeutic Information (CBIP/BCFI)

  2. Leentjes AFG, Kragten JA. Totaal atrioventriculair blok tijdens behandeling met galantamine. Ned Tijdschr Geneesk 2006; 150: 563–6

    Google Scholar 

  3. Anonymous. Maladie d’Alzheimer: gare aux interactions avec les anticholinestérasiques. La Revue Prescrire 2006; 26: 111–5

  4. Anonymous. Effect indésirables cardiaques des inhibiteurs des cholinestérases/Cardiale ongewenste effecten van cholinesterase-inhibitoren. Folia Pharmacotherapeutica 2006; 33:54 (via http://www.cbip.be/http://www.bcfi.be)

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roisin, T., Van Ermen, A. & Rogiers, A. ABSTRACTS: ISoP Annual Conference ‘Joining Forces for Managing Risks’ Liège, Belgium 11–13 October, 2006. Drug-Safety 29, 944 (2006). https://doi.org/10.2165/00002018-200629100-00041

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-200629100-00041

Keywords

Navigation